PC3
PC3 is a human prostate cancer cell line commonly used in cancer research and drug discovery. It was originally derived from a bone metastasis of a grade IV prostate adenocarcinoma from a 62-year-old Caucasian male. PC3 cells are known for their aggressive nature and are used extensively to study the mechanisms of prostate cancer progression and metastasis.
Characteristics[edit]
PC3 cells exhibit an epithelial morphology and are characterized by their high proliferative capacity and ability to form tumors in immunocompromised mice. They are androgen-independent, meaning they do not require androgens for growth, which makes them a valuable model for studying advanced prostate cancer that no longer responds to androgen deprivation therapy.
Applications[edit]
PC3 cells are widely used in various areas of cancer research, including:
- Drug screening: Testing the efficacy of new anticancer drugs.
- Molecular biology: Studying the genetic and molecular pathways involved in prostate cancer.
- Metastasis research: Investigating the mechanisms by which prostate cancer spreads to other parts of the body, particularly the bone.
Culturing PC3 Cells[edit]
PC3 cells are typically cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. They are maintained at 37°C in a humidified atmosphere containing 5% carbon dioxide (CO2).
See also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
